BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 527340)

  • 1. Serum prolactin concentrations related to copper or inert intrauterine devices (IUDs) in women.
    Ransom WT; Chapman RS; Hull MG
    Contraception; 1979 Nov; 20(5):441-6. PubMed ID: 527340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early chorionic activity in women bearing inert IUD, copper IUD and levonorgestrel-releasing IUD.
    Videla-Rivero L; Etchepareborda JJ; Kesseru E
    Contraception; 1987 Aug; 36(2):217-26. PubMed ID: 3123135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of intrauterine contraceptive devices on the endometrium].
    Sheppard BL; Bonnar J
    Contracept Fertil Sex (Paris); 1987 Nov; 15(11):1015-24. PubMed ID: 12341565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The response of endometrial blood vessels to intrauterine contraceptive devices: an electron microscopic study.
    Sheppard BL; Bonnar J
    Br J Obstet Gynaecol; 1980 Feb; 87(2):143-54. PubMed ID: 7362802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum prolactin levels in lactating women using progestasert system.
    Badraoui MH; Askalani H; Mahrous I; Osman MI; Bayad MA; Ibrahim II; Abdalla MT
    Popul Sci; 1981; (2):115-20. PubMed ID: 12339477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experience with two different medicated intrauterine devices: a comparative study of the Progestasert and Nova-T.
    Fylling P; Fagerhol M
    Fertil Steril; 1979 Feb; 31(2):138-41. PubMed ID: 761675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short notes on intrauterine devices.
    Indian J Med Sci; 1990 May; 44(5):129-33. PubMed ID: 2397950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of intrauterine devices containing zinc and copper on their levels in serum.
    Anteby SO; Bassat HA; Yarkoni S; Aboulafia Y; Sadovsky E
    Fertil Steril; 1978 Jan; 29(1):30-4. PubMed ID: 620840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two years' experience with two levonorgestrel-releasing intrauterine devices and one copper-releasing intrauterine device: a randomized comparative performance study.
    Nilsson CG; Allonen H; Diaz J; Luukkainen T
    Fertil Steril; 1983 Feb; 39(2):187-92. PubMed ID: 6401636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Invasive cervical cancer and intrauterine device use.
    Lassise DL; Savitz DA; Hamman RF; Barón AE; Brinton LA; Levines RS
    Int J Epidemiol; 1991 Dec; 20(4):865-70. PubMed ID: 1800424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of intrauterine contraceptive devices on the ultrastructure of the endometrium in relation to bleeding complications.
    Sheppard BL; Bonnar J
    Am J Obstet Gynecol; 1983 Aug; 146(7):829-39. PubMed ID: 6869454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Intrauterine contraception in women over 35-years old: comparison between copper and progesterone IUDs].
    Calzolari E; Galoppi P; Masala L; Parisi C; Iannucci D; Salmaggi P; Custo GM; Zichella L
    Patol Clin Ostet Ginecol; 1985; 13(1):49-56. PubMed ID: 12342024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrauterine devices. The optimal long-term contraceptive method?
    Fortney JA; Feldblum PJ; Raymond EG
    J Reprod Med; 1999 Mar; 44(3):269-74. PubMed ID: 10202746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scanning and transmission electron microscopy of material adherent to intrauterine contraceptive devices.
    Sheppard BL; Bonnar J
    Br J Obstet Gynaecol; 1980 Feb; 87(2):155-62. PubMed ID: 7362803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrauterine devices: an effective alternative to oral hormonal contraception.
    Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Menstrual characteristics and ultrasonographic uterine cavity measurements predict bleeding and pain in nulligravid women using intrauterine contraception.
    Kaislasuo J; Heikinheimo O; Lähteenmäki P; Suhonen S
    Hum Reprod; 2015 Jul; 30(7):1580-8. PubMed ID: 25990577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The end of IUD marketing in the United States: what does it mean for American women?].
    Forrest JD
    Contracept Fertil Sex (Paris); 1987 Mar; 15(3):291-300. PubMed ID: 12341479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum copper in long-term users of copper intrauterine devices.
    Prema K; Lakshmi BA; Babu S
    Fertil Steril; 1980 Jul; 34(1):32-5. PubMed ID: 7398904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrastructure responses of human endometrium to inert and copper IUDs as viewed by scanning electron microscopy.
    El-badrawi HH; Hafez ES; Fayad M; Shafeek A
    Contracept Deliv Syst; 1980 Apr; 1(2):103-11. PubMed ID: 12336235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative prolactin profiles in IUD users and non-IUD users.
    Adejuwon CA; Segal SJ; Faundes A; Alvarez-Sanchez F
    Contraception; 1982 Jun; 25(6):613-8. PubMed ID: 7116848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.